HaTay Pharmaceutical JSC (DHT.VN) Stock Price
HaTay Pharmaceutical JSC Price
Over the last 17 years HaTay Pharmaceutical JSC grew revenue by 8.3% annually, reaching 2.09 T VND. Earnings per share have grown at 1.0% per year over the last 17 years. For HaTay Pharmaceutical JSC, the net margin of 3.4% is down versus 4.6% a few years ago. At today's price the dividend yield works out to roughly 2.02%. The payout ratio is around 126% of earnings.
HaTay Pharmaceutical JSC stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
HaTay Pharmaceutical JSC business model & stock analysis
Frequently asked questions about HaTay Pharmaceutical JSC
Converted at the current exchange rate, the HaTay Pharmaceutical JSC share trades at 1.70 EUR (49,400.00 VND).
The revenue cannot currently be calculated for HaTay Pharmaceutical JSC.
The profit cannot currently be calculated for HaTay Pharmaceutical JSC.
The P/E ratio cannot be calculated for HaTay Pharmaceutical JSC at the moment.
The P/S cannot be calculated for HaTay Pharmaceutical JSC currently.
The Eulerpool Quality Score for HaTay Pharmaceutical JSC is 6/10.
The ISIN of HaTay Pharmaceutical JSC is VN000000DHT3. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of HaTay Pharmaceutical JSC is DHT.VN. The ticker symbol is used to trade HaTay Pharmaceutical JSC shares on the stock exchange.
HaTay Pharmaceutical JSC stock
HaTay Pharmaceutical JSC Peer Group
HaTay Pharmaceutical JSC FIGI
All fundamentals and in-depth analysis of HaTay Pharmaceutical JSC
Our stock analysis for HaTay Pharmaceutical JSC stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of HaTay Pharmaceutical JSC. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.